Literature DB >> 3815159

Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.

G Corthier, F Dubos, R Ducluzeau.   

Abstract

Oral preventive treatment of gnotobiotic mice by Saccharomyces boulardii significantly decreased mortality following Clostridium difficile infection. A single S. boulardii ingestion protected 16% of mice, whereas 56% were protected when S. boulardii was given continuously in the drinking water. No direct antagonistic effect of the yeast on C. difficile numbers was detected, whereas a modulation of fecal cytotoxin production was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3815159     DOI: 10.1139/m86-164

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  18 in total

1.  Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells.

Authors:  D Czerucka; P Rampal
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.

Authors:  D M Lyerly; E F Bostwick; S B Binion; T D Wilkins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.

Authors:  I Castagliuolo; M F Riegler; L Valenick; J T LaMont; C Pothoulakis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters.

Authors:  C M Kotz; L R Peterson; J A Moody; D A Savaiano; M D Levitt
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

5.  Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats.

Authors:  A V Boddy; G W Elmer; L V McFarland; R H Levy
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

6.  Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.

Authors:  B Schroeder; C Winckler; K Failing; G Breves
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one.

Authors:  G Corthier; M C Muller
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

8.  Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.

Authors:  Fariborz Mansour-Ghanaei; Najaf Dehbashi; Kamyar Yazdanparast; Afshin Shafaghi
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.

Authors:  Karen L Mumy; Xinhua Chen; Ciarán P Kelly; Beth A McCormick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-21       Impact factor: 4.052

10.  Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.

Authors:  Philippe Girard; Yannick Pansart; Ingrid Lorette; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.